Impact of life stage and duration of exposure on arsenic-induced proliferative lesions and neoplasia in C3H mice

Toxicology

Volumn 262, Issue 2, 2009, Pages 106-113

  Ahlborn, Gene J ^a,b   Nelson, Gail M ^a   Grindstaff, Rachel D ^a   Waalkes, Michael P ^c   Diwan, Bhalchandra A ^d   Allen, James W ^a   Kitchin, Kirk T ^a   Preston, R Julian ^a   Hernandez Zavala, Araceli ^e   Adair, Blakely ^a   Thomas, David J ^a   Delker, Don A ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Age susceptibility; Arsenic; C3H mice; Carcinogenesis; Life stage; Urinary bladder

Indexed keywords

ARSENIC; DRINKING WATER;

ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER TUMOR; C3H MOUSE; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; LIPID METABOLISM; LIVER ADENOMA; LIVER CARCINOMA; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; OVARY TUMOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; UROGENITAL TRACT TUMOR; UTERUS TUMOR;

ADMINISTRATION, ORAL; ADRENAL GLAND NEOPLASMS; ANIMALS; ARSENITES; CARCINOGENS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HYPERPLASIA; LIVER NEOPLASMS; MALE; MATERNAL EXPOSURE; MATERNAL-FETAL EXCHANGE; MICE; MICE, INBRED C3H; OVIDUCTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SODIUM COMPOUNDS; TIME FACTORS; URINARY BLADDER; WATER SUPPLY;

MUS;

EID: 67649998481     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.05.003     Document Type: Article

References (40)

1. Arnold L.L., Eldan M., et al. Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice. Toxicology 223 1-2 (2006) 82-100
2. Bates M.N., Smith A.H., et al. Case-control study of bladder cancer and arsenic in drinking water. Am. J. Epidemiol. 141 6 (1995) 523-530
3. Bates M.N., Smith A.H., et al. Arsenic ingestion and internal cancers: a review. Am. J. Epidemiol. 135 5 (1992) 462-476
4. Chiou H.Y., Hsueh Y.M., et al. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55 6 (1995) 1296-1300
5. Cohen S.M., Arnold L.L., et al. Methylated arsenicals: the implications of metabolism and carcinogenicity studies in rodents to human risk assessment. Crit. Rev. Toxicol. 36 2 (2006) 99-133
6. Devesa V., Adair B.M., et al. Arsenicals in maternal and fetal mouse tissues after gestational exposure to arsenite. Toxicology 224 1-2 (2006) 147-155
7. Devesa V., Suner M.A., et al. Organoarsenical species contents in cooked seafood. J. Agric. Food Chem. 53 22 (2005) 8813-8819
8. Falvella F.S., Pascale R.M., et al. Stearoyl-CoA desaturase 1 (Scd1) gene overexpression is associated with genetic predisposition to hepatocarcinogenesis in mice and rats. Carcinogenesis 23 11 (2002) 1933-1936
9. Ferreccio C., Gonzalez C., et al. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 11 6 (2000) 673-679
10. Fry R.C., Navasumrit P., et al. Activation of inflammation/NF-kB signaling in infants born to arsenic-exposed mothers. PLoS Genet. 3 11 e207 (2007) e207: 2180-2189
11. Germolec D.R., Spalding J., et al. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386 3 (1997) 209-218
12. Hall M., Gamble M., et al. Determinants of arsenic metabolism: blood arsenic metabolites, plasma folate, cobalamin, and homocysteine concentrations in maternal-newborn pairs. Environ. Health Perspect. 115 10 (2007) 1503-1509
13. Haque R., Mazumder D.N., et al. Arsenic in drinking water and skin lesions: dose-response data from West Bengal, India. Epidemiology 14 2 (2003) 174-182
14. Hopenhayn-Rich C., Biggs M.L., et al. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 27 4 (1998) 561-569
15. Hughes M.F., Devesa V., et al. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration. Toxicol. Appl. Pharmacol. 208 2 (2005) 186-197
16. International Agency for Research on Cancer (IARC). Monographs on evaluation of carcinogenic risk to humans. Some Drinking Water Disinfectants and Contaminants, Including Arsenic vol. 84 (2004), IARC Press, Lyon pp. 269-477
17. Kitchin K.T. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172 3 (2001) 249-261
18. Kligerman A.D., and Tennant A.H. Insights into the carcinogenic mode of action of arsenic. Toxicol. Appl. Pharmacol. 222 3 (2007) 281-288
19. Liu B., Pan S., et al. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci. 97 7 (2006) 675-681
20. Marshall G., Ferreccio C., et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer Inst. 99 12 (2007) 920-928
21. Mizoi M., Takabayashi F., et al. The role of trivalent dimethylated arsenic in dimethylarsinic acid-promoted skin and lung tumorigenesis in mice: tumor-promoting action through the induction of oxidative stress. Toxicol. Lett. 158 2 (2005) 87-94
22. Morikawa T., Wanibuchi H., et al. Promotion of skin carcinogenesis by dimethylarsinic acid in keratin (K6)/ODC transgenic mice. Jpn. J. Cancer Res. 91 6 (2000) 579-581
23. Motiwale L., Ingle A.D., et al. Mouse skin tumor promotion by sodium arsenate is associated with enhanced PCNA expression. Cancer Lett. 223 1 (2005) 27-35
24. Newbold R.R., Bullock B.C., et al. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res. 50 23 (1990) 7677-7681
25. NRC. Arsenic in the Drinking Water (1999), National Research Council, National Academy, Washington, DC
26. Ntambi J.M. Regulation of stearoyl-CoA desaturase by polyunsaturated fatty acids and cholesterol. J. Lipid Res. 40 9 (1999) 1549-1558
27. Ntambi J.M., Miyazaki M., et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. U.S.A. 99 17 (2002) 11482-11486
28. Pott W.A., Benjamin S.A., et al. Pharmacokinetics, metabolism, and carcinogenicity of arsenic. Rev. Environ. Contam. Toxicol. 169 (2001) 165-214
29. Rice J.M. Carcinogenesis: a late effect of irreversible toxic damage during development. Environ. Health Perspect. 18 (1976) 133-139
30. Rossman T.G. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533 1-2 (2003) 37-65
31. Rossman T.G., Uddin A.N., et al. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol. Appl. Pharmacol. 198 3 (2004) 394-404
32. Simeonova P.P., and Luster M.I. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms?. J. Environ. Pathol. Toxicol. Oncol. 19 3 (2000) 281-286
33. Smith A.H., Marshall G., et al. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114 8 (2006) 1293-1296
34. Uddin A.N., Burns F.J., et al. Vitamin E and organoselenium prevent the cocarcinogenic activity of arsenite with solar UVR in mouse skin. Carcinogenesis 26 12 (2005) 2179-2186
35. Waalkes M.P., Liu J., et al. Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol. Appl. Pharmacol. 198 3 (2004) 377-384
36. Waalkes M.P., Liu J., et al. Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96 (2004) 466-474
37. Waalkes M.P., Liu J., et al. Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 66 3 (2006) 1337-1345
38. Waalkes M.P., Ward J.M., et al. Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice. Toxicol. Appl. Pharmacol. 186 1 (2003) 7-17
39. Wei M., Wanibuchi H., et al. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23 8 (2002) 1387-1397
40. Wei M., Wanibuchi H., et al. Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20 9 (1999) 1873-1876